BAFFR

BAFFR

BAFFR 분자 정보

Molecule Name
B-cell activating factor receptor
분자 별명
BAFFR,TNFRSF13C,BROMIX,CD268,CVID4,prolixin,BAFF-R
Drug Development Progress
임상 약물 수14
시판 약물 수0
최고 연구 개발 단계NDA/BLA
표적 별명
BAFFR,B Cell-Activating Factor Receptor,Prolixin,BROMIX,CD268,Tumor Necrosis Factor Receptor Superfamily, Member 13C,Tumor Necrosis Factor Receptor Superfamily Member 13C,BR3,CVID4,CD268 Antigen,BAFF Receptor,B-Cell Activation Factor Receptor,BAFF-R,TNF Receptor Superfamily Member 13C,BLyS Receptor 3,B-Cell-Activating Factor Receptor,TNFRSF13C
분자 배경
BAFF receptor (B-cell activating factor receptor, BAFF-R), also known as tumor necrosis factor receptor superfamily member 13C (TNFRSF13C), is a membrane protein of the TNF receptor superfamily which recognizes BAFF. B-cell activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. Overexpression of BAFF in mice results in mature B-cell hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE patients have increased levels of BAFF in serum. Therefore, it has been proposed that abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune diseases by enhancing the survival of autoreactive B cells.

BAFFR 제품 목록

Species
  • Human(5)
  • Mouse(3)
  • Cynomolgus(2)
  • Rat(1)
Tag
  • His Tag(4)
  • Fc Tag(3)
  • Fc Tag & Avi Tag(2)
  • His Tag & Avi Tag(1)
  • Llama IgG Fc Tag(1)
Host
  • HEK293(11)
Conjugate
  • Unconjugated(8)
  • Biotin-labeled(3)
Grade
  • RUO(11)
Low Endotoxin
  • Yes(2)
  • No(9)
You Have Viewed 1-10 Of 11 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity

항체 프로젝트 거래 플랫폼

프로젝트 이름프로젝트 단계분자 유형분자 출처질병 영역적응증
BAFFR&CD3 BsAb - 01PCCBispecificHumanized Mouse,NanobodyHematological Malignancy,AutoImmunityBlood tumor,Autoimmune disease
프로젝트 이름
BAFFR&CD3 BsAb - 01
프로젝트 단계
PCC
분자 유형
Bispecific
분자 출처
Humanized Mouse,Nanobody
질병 영역
Hematological Malignancy,AutoImmunity
적응증
Blood tumor,Autoimmune disease
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Fully Human BAFF-R Chimeric Antigen Receptor T-Cell (Taihe Chunyu)Phase 2 ClinicalHebei Tahoe Chunyu Biotechnology Co Ltd
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Waldenstrom Macroglobulinemia
상세
Anti-BAFFR CAR T therapy(The General Hospital Of Tianjin Medical University)BAFFR CARTPhase 2 ClinicalThe General Hospital Of Tianjin Medical University
Myasthenia Gravis; Myositis; Neuromyelitis Optica; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
상세
ESG-206ESG-206Phase 2 ClinicalShanghai Escugen Biotechnology Co Ltd
Lupus Erythematosus, Systemic; Lymphoma, B-Cell; Neoplasms; Purpura, Thrombocytopenic, Idiopathic; Sjogren's Syndrome
상세
dual anti-CD19/anti-BAFF CAR T-cell therapy (Shanghai YaKe Biotechnology/Zhejiang University)Phase 1 ClinicalShanghai Yake Biotechnology Co Ltd
Autoimmune Diseases; Dermatomyositis; Lupus Erythematosus, Systemic; Nephritis; Neuromyelitis Optica; Scleroderma, Systemic
상세
SSS-68SSS68; SSS-68Phase 1 ClinicalShenyang Sunshine Pharmaceutical Co Ltd
Glomerulonephritis, IGA
상세
BAFF-R CAR-T cells therapy (Topcel-KH Pharmaceutical)Phase 1 ClinicalJiangsu Topcel-KH Pharmaceutical Co Ltd
Lymphoma, B-Cell
상세
BAFFR CAR-T cell therapy (Bio-gene Technology)Phase 1 ClinicalGuangzhou Bio-Gene Technology Co Ltd
Precursor Cell Lymphoblastic Leukemia-Lymphoma
상세
LY-4152199LY-4152199; LY4152199Phase 1 ClinicalEli Lilly And Company
Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin
상세
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells therapy(Mayo Clinic)MC10029; MC-10029Phase 1 ClinicalMayo Clinic
Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell
상세
CD19-BAFF Targeted CAR T-cells Therapy(YaKe Biotechnology)Phase 1 ClinicalShanghai YaKe Biotechnology Co Ltd, Zhejiang University
Autoimmune Diseases; Lymphoma, B-Cell; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
상세
KD-6005KD-6005; KD6005Phase 1 ClinicalShanghai Celgen Bio-Pharmaceutical Co Ltd, Shanghai Kanda Bio-Technology Co Ltd
Arthritis, Rheumatoid
상세
AritinerceptAUR-200; AUR200Phase 1 ClinicalThunderbolt Pharma Inc
Autoimmune Diseases
상세
JH-013JH-013Phase 1 ClinicalBiotech Pharmaceuticals Co Ltd
Arthritis, Rheumatoid; Hematologic Neoplasms; Lupus Erythematosus, Systemic; Sjogren's Syndrome
상세
BAFFR-CAR T cell therapy (PeproMene Bio)PMB-101; PMB-CT01Phase 1 ClinicalCity Of Hope National Medical Center, PeproMene Bio Inc
Leukemia, Biphenotypic, Acute; Lymphoma, B-Cell; Lymphoma, Follicular; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
상세
Customer Reviews